NewAmsterdam Pharma (NAMS) Debt to Equity (2022 - 2026)
NewAmsterdam Pharma's (NAMS) quarterly Debt to Equity came in at $0.08 in Q1 2026, up 149.53% year-on-year from $0.03 in Q1 2025, and down 9.9% quarter-over-quarter from $0.08 in Q4 2025.
NewAmsterdam Pharma (NAMS) Debt to Equity (2022 - 2026) Analysis & Trends
NewAmsterdam Pharma has disclosed Debt to Equity across 5 years of filings, most recently posting $0.08 for Q1 2026.
- Debt to Equity for Q1 2026 came in at $0.08, up 149.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.08 (up 149.53% YoY), and the FY2025 annual result was $0.08, up 69.21% from the prior year.
- Debt to Equity came in at $0.08 for Q1 2026 at NewAmsterdam Pharma, down from $0.08 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.08 in Q4 2025 to a low of $0.0 in Q2 2023.
- The 5-year median for Debt to Equity is $0.05 (2024), against an average of $0.05.
- Across the five-year window, Debt to Equity soared 269546.47% in 2024 and tumbled 62.31% in 2025, its largest moves.
- NewAmsterdam Pharma's Debt to Equity stood at $0.01 in 2022, then soared by 443.34% to $0.04 in 2023, then climbed by 13.59% to $0.05 in 2024, then soared by 69.21% to $0.08 in 2025, then dropped by 9.9% to $0.08 in 2026.
- The last three Debt to Equity figures came in at $0.08 (Q1 2026), $0.08 (Q4 2025), and $0.06 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | NewAmsterdam Pharma | 3.63 Bn | 3.63 Bn | - | 0.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.08 |
| Dec 31, 2025 | 0.08 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | 0.03 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | 0.06 |
| Mar 31, 2024 | 0.08 |
| Dec 31, 2023 | 0.04 |
| Jun 30, 2023 | 0.00 |
| Dec 31, 2022 | 0.01 |